Randomized trial demonstrates hypoglycemic effects in an insulin-resistant model, suggesting potential benefits for glucose metabolism.
M for α-glucosidase. Within the tested range, its inhibitory activity was stronger than that of Astragalus polysaccharide (APS) but weaker than that of acarbose. In a palmitic acid-induced insulin-resistant HepG2 model, BPS-2 significantly enhanced glucose consumption and increased 2-Deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl) amino]-D-glucose (2-NBDG) uptake by 44.9% at 0.75 mg/mL without detectable cytotoxicity, suggesting a potential role in improving cellular glucose utilization under insulin-resistant conditions. To the best of our knowledge, this is the first report describing hypoglycemic-related activity of extracellular polysaccharides derived from deep-sea B. bassiana. These findings provide initial evidence linking the structural features of BPS-2 to glucose metabolism-associated bioactivity, while further studies are required to clarify detailed structural characteristics and underlying molecular mechanisms.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: